A significant philanthropic commitment to mental health research has reached a new milestone. The Stanley Family Foundation recently announced an additional $280 million donation to the Stanley Center for Psychiatric Research at the Broad Institute.

The Catalyst: A Family's Fight Against Bipolar Disorder

This substantial funding brings the Stanley family's total contributions to the Massachusetts-based nonprofit past the $1 billion mark. The dedication stems directly from the family's personal struggles with severe mental illness.

Jon Stanley, whose parents were Ted and Vada Stanley, experienced severe episodes of bipolar disorder starting at age 19. He recalled a period of "full-brained mania" nearly four decades ago that led to a frightening public incident in a New York City deli.

Early Struggles with Treatment

When Jon sought help in 1987, severe mental health care felt like "more art than science," according to his recollection. Doctors often rotated medications in a trial-and-error approach, hoping something would prove effective.

Jon's initial treatment involved lithium, but it was the later addition of the anticonvulsant Tegretol that finally stabilized him. Notably, neither drug was originally developed to treat bipolar disorder at that time.

The Birth of a Philanthropic Mission

These difficult experiences inspired Jon’s late parents, Ted and Vada Stanley, to dedicate vast resources toward research for bipolar disorder and schizophrenia treatments. Ted Stanley, a successful retailer, envisioned a major research effort, which Jon described as his father wanting his own "Manhattan Project."

The Stanleys initially established the Stanley Medical Research Institute. However, Ted grew frustrated with traditional academic grant models, preferring a unified approach to research.

A Focused Commitment to the Broad Institute

Ted Stanley eventually decided to concentrate nearly all his philanthropic efforts on the Broad Institute, which launched in 2004 to integrate research from MIT and Harvard faculty.

"We give all the money to Broad and they’re all looking at the one problem," Jon stated, emphasizing the desire for a cohesive, "wartime economy" approach to solving these illnesses.

Ted Stanley devoted $825 million during his lifetime. Due to strong stock market performance, additional funds became available for commitment.

Accelerating Psychiatric Research

Jon Stanley, serving as a trustee for the family foundation, affirmed his commitment to continuing his father's vision. He believes it is his obligation to ensure the wealth is used as his father intended: to fund further research.

The latest $280 million gift will support seven more years of work at the Stanley Center for Psychiatric Research. The goal is to leverage rapid advancements in DNA sequencing to speed up the development of new interventions.

Progress and Future Goals

Benjamin Neale, co-director of the Stanley Center, confirmed major discoveries regarding genes that significantly increase the risk for these illnesses. However, he stressed that much more genetic understanding is still needed.

Neale stated, "We know we only have a small fraction of what is out there to be discovered." His primary goal for the next decade is to catalyze clinical trials for new treatments for schizophrenia and bipolar disorder.

The Stanleys value the Broad Institute's process, where analysis and learning occur even when experiments do not yield immediate success. Jon noted, "They’ll notice things and analyze the data in a way that, even if it doesn’t work, they’ll learn something."